Literature DB >> 17996555

Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate.

Harvey Chim1, Ban Hock Tan, Colin Song.   

Abstract

A 5-year review of nosocomial infections, bacteraemia and wound colonization in patients admitted to a burn intensive care unit from June 2001 to May 2006 was carried out. All patients required intubation at some point, and ICU support. Data on bacterial and fungal isolates were entered prospectively into a hospital-wide computerized database. Nosocomial infections (NIs) were defined using standard CDC criteria. Seventy-six patients were admitted during the study period, with 57 qualifying for analysis. Forty-two patients (74%) developed 137 NIs, with 240 NIs/100 admissions. The most common NI was pneumonia (43%), followed by burn wound infection (34%), primary bloodstream infection (20%) and urinary tract infection (3%). The device specific rate of pneumonia was 143 infections per 1000 ventilator days. There were 113 episodes of bacteraemia and 173 episodes of wound colonization without infection. The most common organisms causing nosocomial infections were Acinetobacter sp. (n=33), followed by methicillin resistant Staphylococcus aureus (MRSA) (n=24) and Pseudomonas aeruginosa (n=22). A. baumannii isolates were highly multiresistant, with 82 distinct strains isolated from 47 patients (82% of patients). Data from this and other studies supports the hypothesis that A. baumannii is more common in tropical, warm climes necessitating vigorous infection control measures to optimise patient outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17996555     DOI: 10.1016/j.burns.2007.03.003

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  26 in total

1.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

Review 2.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

Review 3.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

4.  After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients.

Authors:  Katharina Olbrisch; Tobias Kisch; Julia Thern; Evelyn Kramme; Jan Rupp; Tobias Graf; Sebastian G Wicha; Peter Mailänder; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-27       Impact factor: 3.000

5.  Infectious complications in adult burn patients and antimicrobial resistance pattern of microorganisms isolated.

Authors:  E F Zampar; E H T Anami; G Kerbauy; L F T Queiroz; C M D M Carrilho; L T Q Cardoso; C M C Grion
Journal:  Ann Burns Fire Disasters       Date:  2017-12-31

Review 6.  Prophylactic antibiotics for burns patients: systematic review and meta-analysis.

Authors:  Tomer Avni; Ariela Levcovich; Dean D Ad-El; Leonard Leibovici; Mical Paul
Journal:  BMJ       Date:  2010-02-15

Review 7.  Nanofibers offer alternative ways to the treatment of skin infections.

Authors:  T D J Heunis; L M T Dicks
Journal:  J Biomed Biotechnol       Date:  2010-07-28

Review 8.  Infection in Burns.

Authors:  William Norbury; David N Herndon; Jessica Tanksley; Marc G Jeschke; Celeste C Finnerty
Journal:  Surg Infect (Larchmt)       Date:  2016-04       Impact factor: 2.150

9.  Pathogen distribution and drug resistance in a burn ward: a three-year retrospective analysis of a single center in China.

Authors:  Hanghui Cen; Zhenbo Wu; Fan Wang; Chunmao Han
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Pulmonary vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis.

Authors:  Collette C Jonkam; Kamna Bansal; Daniel L Traber; Atsumori Hamahata; Marc O Maybauer; Dirk M Maybauer; Robert A Cox; Matthias Lange; Rhykka L Connelly; Lillian D Traber; Clarisse D Djukom; John R Salsbury; David N Herndon; Perenlei Enkhbaatar
Journal:  Crit Care       Date:  2009-02-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.